CoChat

Intermittent fasting improves hepatic end points in nonalcoholic fatty liver disease: A systematic review and meta-analysis

Open access
Lange, Marcia, Nadkarni, Devika, Martin, Lily, Newberry, Carolyn, Kumar, Sonal, Kushner, Tatyana · 2023 · Hepatology Communications

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Abstract

Background and Aims: Despite NAFLD being the most prevalent liver disease globally, currently there are no FDA-approved treatments, and weight loss through caloric restriction and enhanced physical activity is the recommended treatment strategy. Intermittent fasting (IF) has been proposed as an alternative strategy with additional cardiometabolic benefits. In this systematic review and meta-analysis, we evaluated the anthropometric, biochemical, and hepatic impacts of IF in patients with NAFLD. Methods: MEDLINE, EMBASE, Cochrane Central, and conference abstracts were searched for IF interventions in adults with NAFLD until April 2, 2023. Meta-analysis with a random effects model was used to compare pre-intervention and post-intervention changes in anthropometric, biochemical, and hepatic end points in the IF intervention group with the control group. Publication bias was assessed using Egger’s test. Results: Fourteen studies were included in the systematic review and ten in the meta-analysis (n = 840 participants, 44.64% male). Studies varied in modalities for NAFLD diagnosis, duration of IF (4–52 weeks), and type of IF (5:2 diet, modern alternate-day fasting, time-restricted eating, or religious fasting). Body weight, body mass index, and waist to hip ratio all significantly improved following fasting intervention (p< 0.05). Adults with NAFLD showed an improvement in serum alanine transaminase, aspartate aminotransferase, hepatic steatosis (controlled attenuation parameter measured by vibration-controlled transient elastography), and hepatic stiffness (measured by vibration-controlled transient elastography) after fasting intervention (p < 0.05). Conclusions: There is limited, but moderate- to high-quality evidence to suggest that IF can improve hepatic end points and promote weight loss in adults with NAFLD. Larger randomized controlled studies with extended duration are needed to further validate our findings.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/hc9.0000000000000212

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIGURE 1 PRISMA flowchart of search for study inclusion in the systematic review and meta-analysis. Abbreviations: PRISMA, preferred reporting items for systematic reviews and meta-analyses.
FIGURE 1 PRISMA flowchart of search for study inclusion in the systematic review and meta-analysis. Abbreviations: PRISMA, preferred reporting items for systematic reviews and meta-analyses.CC BY-NC-ND · PubMed Central
FIGURE 2 Risk of bias assessment for studies included in meta-analysis. (A) Risk of bias assessment for nonrandomized double-arm studies using ROBINS-I; (B) Risk of bias assessment for randomized controlled studies using RoB2.
FIGURE 2 Risk of bias assessment for studies included in meta-analysis. (A) Risk of bias assessment for nonrandomized double-arm studies using ROBINS-I; (B) Risk of bias assessment for randomized controlled studies using RoB2.CC BY-NC-ND · PubMed Central
FIGURE 3 Pooled analysis of the impact of intermittent fasting on anthropometric end points. Forest plots correspond to pooled analysis of body weight (A), BMI (B), WHR (C), and WC (D). Abbreviations: BMI, body mass index; WC, waist circumference; WHR, waist to hip ratio.
FIGURE 3 Pooled analysis of the impact of intermittent fasting on anthropometric end points. Forest plots correspond to pooled analysis of body weight (A), BMI (B), WHR (C), and WC (D). Abbreviations: BMI, body mass index; WC, waist circumference; WHR, waist to hip ratio.CC BY-NC-ND · PubMed Central
FIGURE 4 Pooled analysis of the impact of intermittent fasting on biochemical end points. Forest plots correspond to pooled analysis of total cholesterol (A), triglycerides (B), HDL (C), and LDL (D).
FIGURE 4 Pooled analysis of the impact of intermittent fasting on biochemical end points. Forest plots correspond to pooled analysis of total cholesterol (A), triglycerides (B), HDL (C), and LDL (D).CC BY-NC-ND · PubMed Central
FIGURE 5 Pooled analysis of the impact of intermittent fasting on HOMA-IR and fasting glucose. Forest plots correspond to pooled analysis of HOMA-IR (A) and fasting blood glucose level (B). Abbreviations: HOMA-IR, homeostatic model assessment for insulin resistance.
FIGURE 5 Pooled analysis of the impact of intermittent fasting on HOMA-IR and fasting glucose. Forest plots correspond to pooled analysis of HOMA-IR (A) and fasting blood glucose level (B). Abbreviations: HOMA-IR, homeostatic model assessment for insulin resistance.CC BY-NC-ND · PubMed Central
FIGURE 6 Pooled analysis of the impact of intermittent fasting on liver-specific end points. Forest plots for pooled analysis of ALT (A), AST (B), liver steatosis (C), and liver stiffness (D). Abbreviations: ALT, alanine transaminase; AST, aspartate aminotransferase.
FIGURE 6 Pooled analysis of the impact of intermittent fasting on liver-specific end points. Forest plots for pooled analysis of ALT (A), AST (B), liver steatosis (C), and liver stiffness (D). Abbreviations: ALT, alanine transaminase; AST, aspartate aminotransferase.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 40 references

Research works printed but not linked: 4

  1. Di Battista, 2020, The treating liver study: Preliminary findings of a “time re-focused eating” feasibility study for obesity and non-alcoholic fatty liver disease, Obes Rev, 21, S211
  2. Mack, 2014, Non-alcoholic fatty liver disease intermittent fasting time intervention (NIFTI): fasting without calorie restriction improves hepatic transient elastography, visceral adiposity and insulin resistance compared to standard care, J Gastroenterol Hepatol, 29, 68
  3. Rahimi, 2017, Effect of Ramadan Fastin on Alanine Aminotransferase (ALT) in Non-Alcoholic Fatty Liver Disease (NAFLD), J Fast Health, 5, 107
  4. Rynders, 2019, Effectiveness of Intermittent Fasting and Time-Restricted Feeding Compared to Continuous Energy Restriction for Weight Loss, Nutrients, 11, 2442, 10.3390/nu11102442 · DOI · Paper page

Cited by

See all 49

Metadata

Authors
Lange, M., Nadkarni, D., Martin, L., Newberry, C., Kumar, S., & Kushner, T.
Affiliations
  • Icahn School of Medicine at Mount Sinai (US)
  • Cornell University (US)
Corresponding author
Lange, Marcia
Venue
Hepatology Communications
Published
2023-08
Volume
7
Issue
8
ISSN
2471-254X (ISSN-L)
OpenAlex
W4385514946
Cited by
49
References
40
Citations by year
2026: 10 · 2025: 16 · 2024: 19 · 2023: 4
FWCI
1.75
Type
journal article
Language
en
Open access
Locations
  • Hepatology Communications (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
European Association for the Study of the Liver
Topics
  • Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
Keywords
intermittent fasting, non-alcoholic fatty liver disease, weight loss, anthropometric outcomes, alanine aminotransferase, aspartate aminotransferase, hepatic steatosis, liver stiffness, controlled attenuation parameter, vibration-controlled transient elastography, time-restricted eating, alternate-day fasting, 5:2 diet, religious fasting
MeSH terms
Intermittent Fasting, Adult, Diet, Female, Humans, Male, Weight Loss, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Intermittent fasting improves hepatic end points in nonalcoholic fatty liver disease: A systematic review and meta-analysis. https://app.cochat.ai/papers/10.1097/hc9.0000000000000212
The paper
Lange, M., Nadkarni, D., Martin, L., Newberry, C., Kumar, S., & Kushner, T. (2023). Intermittent fasting improves hepatic end points in nonalcoholic fatty liver disease: A systematic review and meta-analysis. Hepatology Communications. https://doi.org/10.1097/hc9.0000000000000212

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.